OriCAR-017

· OriCell Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OriCAR-017, covering 2024-05-31 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study [Phase 1]